Unity Biotechnology (NASDAQ:UBX) Cut to “Neutral” at Mizuho
Unity Biotechnology (NASDAQ:UBX – Get Free Report) was downgraded by Mizuho from an “outperform” rating to a “neutral” rating in a research note issued to investors on Friday, MarketBeat.com reports. They currently have a $1.00 price objective on the stock, down from their previous price objective of $6.00. Mizuho’s price target would suggest a potential […]
Unity Biotechnology (NASDAQ:UBX – Get Free Report) was downgraded by Mizuho from an “outperform” rating to a “neutral” rating in a research note issued to investors on Friday, MarketBeat.com reports. They currently have a $1.00 price objective on the stock, down from their previous price objective of $6.00. Mizuho’s price target would suggest a potential […]
